Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis

NCT04120519 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: thalidomide combined with dexamethasone and cyclophosphamide

Sponsor

Peking Union Medical College Hospital